The U.S. Supreme Court has declined to hear POM Wonderful LLC’s petition for writ of certiorari regarding a 2013 FTC decision that found some of POM Wonderful’s health related claims to be misleading. As a result, the FTC ‘s January 2013 order against POM Wonderful will stand. FTC’s REsponse to Supreme Court’s Denial of Appeal […]
Hi-Tech Pharmaceuticals recently won its appeal of a $40 million judgment ordered by a federal district judge regarding the double-blind placebo tests.
The FTC has challenged MelApp and Mole Detective, makers of melanoma detecting mobile apps that claim to detect melanoma at early stages.
The D.C. Circuit issued its opinion in the POM Wonderful case. The court’s opinion affirmed the FTC’s decision that POM Wonderful deceptively advertised.